Largest health care companies
The 1,020 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.045 T
9.1% of all US-listed value
Companies
1,020
Ranked #4 of 12 sectors
Average
$8.868 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.08T | $1,150.99 | -1.64% | United States |
| 2 | Johnson & JohnsonJNJ | $648.7B | $269.17 | -0.01% | United States |
| 3 | AbbVieABBV | $468.4B | $265.08 | -0.05% | United States |
| 4 | Merck & Co.MRK | $365.3B | $148.08 | -1.88% | United States |
| 5 | UnitedHealth GroupUNH | $333.3B | $371.29 | -0.45% | United States |
| 6 | Philip Morris InternationalPM | $297.4B | $190.84 | +0.32% | United States |
| 7 | NovartisNVS | $272.3B | $142.71 | +1.01% | Switzerland |
| 8 | AstrazenecaAZN | $253.3B | $163.33 | -2.99% | United Kingdom |
| 9 | AmgenAMGN | $219.5B | $406.09 | -1.01% | United States |
| 10 | Gilead SciencesGILD | $187.7B | $151.37 | -0.85% | United States |
| 11 | Abbott LaboratoriesABT | $179.1B | $103.49 | -0.19% | United States |
| 12 | Novo Nordisk A SNVO | $169.0B | $38.17 | -3.12% | Denmark |
| 13 | PfizerPFE | $160.6B | $28.18 | +0.90% | United States |
| 14 | Intuitive SurgicalISRG | $140.7B | $398.30 | -0.94% | United States |
| 15 | Vertex PharmaceuticalsVRTX | $130.9B | $516.34 | +0.26% | United States |
| 16 | Bristol Myers SquibbBMY | $124.9B | $61.15 | -1.77% | United States |
| 17 | British American Tobacco p.l.c.BTI | $120.7B | $55.85 | +0.18% | United Kingdom |
| 18 | Altria GroupMO | $115.1B | $68.95 | +0.45% | United States |
| 19 | MedtronicMDT | $114.2B | $89.30 | -1.62% | United States |
| 20 | StrykerSYK | $104.9B | $273.40 | -0.61% | United States |
| 21 | McKessonMCK | $102.7B | $880.50 | -1.20% | United States |
| 22 | SanofiSNY | $101.6B | $41.66 | -2.00% | France |
| 23 | GSKGSK | $100.5B | $49.71 | -1.99% | United Kingdom |
| 24 | HCA HealthcareHCA | $94.5B | $436.48 | -0.37% | United States |
| 25 | 3MMMM | $87.8B | $170.30 | +0.59% | United States |
| 26 | Elevance HealthELV | $86.4B | $398.56 | -0.96% | United States |
| 27 | Regeneron PharmaceuticalsREGN | $82.6B | $801.82 | -0.26% | United States |
| 28 | ModernaMRNA | $72.7B | $182.11 | -0.25% | United States |
| 29 | Cigna GroupCI | $70.9B | $268.27 | -2.00% | United States |
| 30 | Boston ScientificBSX | $64.7B | $44.62 | -0.67% | United States |
| 31 | CencoraCOR | $59.6B | $312.28 | -0.68% | United States |
| 32 | Takeda PharmaceuticalTAK | $59.4B | $18.81 | -0.74% | Japan |
| 33 | Argenx SeARGX | $58.7B | $945.82 | -1.86% | Netherlands |
| 34 | NateraNTRA | $56.3B | $390.79 | -0.03% | United States |
| 35 | Cardinal HealthCAH | $51.2B | $221.27 | -0.35% | United States |
| 36 | Edwards LifesciencesEW | $50.0B | $86.82 | -2.21% | United States |
| 37 | Becton Dickinson & CoBDX | $49.7B | $182.52 | -0.26% | United States |
| 38 | Teva Pharmaceutical IndustriesTEVA | $45.5B | $39.01 | -1.29% | Israel |
| 39 | MedlineMDLN | $45.1B | $34.30 | -0.38% | United States |
| 40 | HumanaHUM | $45.0B | $374.78 | +0.75% | United States |
| 41 | IqviaIQV | $44.1B | $267.86 | -0.83% | United States |
| 42 | BeOne MedicinesONC | $41.5B | $365.00 | -0.84% | Cayman Islands |
| 43 | Idexx LaboratoriesIDXX | $41.1B | $522.02 | +0.10% | United States |
| 44 | Revolution MedicinesRVMD | $40.9B | $190.74 | -1.10% | United States |
| 45 | IlluminaILMN | $38.6B | $255.38 | +3.20% | United States |
| 46 | BiogenBIIB | $33.6B | $227.53 | +0.96% | United States |
| 47 | Royalty PharmaRPRX | $33.1B | $57.65 | -1.49% | United States |
| 48 | DexcomDXCM | $33.1B | $87.73 | -2.01% | United States |
| 49 | Alnylam PharmaceuticalsALNY | $33.0B | $246.51 | -2.04% | United States |
| 50 | AlconALC | $32.7B | $65.39 | -0.30% | Switzerland |
| 51 | ResmedRMD | $32.1B | $222.30 | +0.15% | United States |
| 52 | CenteneCNC | $30.7B | $62.08 | -1.93% | United States |
| 53 | GE HealthCare TechnologiesGEHC | $29.9B | $66.09 | -0.27% | United States |
| 54 | ZoetisZTS | $29.6B | $71.61 | -1.72% | United States |
| 55 | Roivant SciencesROIV | $26.6B | $36.82 | -3.66% | United Kingdom |
| 56 | West Pharmaceutical ServicesWST | $26.5B | $375.87 | +1.29% | United States |
| 57 | InsmedINSM | $25.8B | $118.34 | -2.05% | United States |
| 58 | Quest DiagnosticsDGX | $25.7B | $233.00 | -0.75% | United States |
| 59 | IncyteINCY | $25.3B | $124.64 | -1.80% | United States |
| 60 | BioNTech SEBNTX | $24.7B | $98.46 | -2.39% | Germany |
| 61 | LabcorpLH | $24.7B | $303.98 | -2.43% | United States |
| 62 | Koninklijke PhilipsPHG | $24.0B | $24.45 | -2.08% | Netherlands |
| 63 | Guardant HealthGH | $23.7B | $176.31 | -0.48% | United States |
| 64 | United TherapeuticsUTHR | $21.0B | $489.42 | -1.64% | United States |
| 65 | Tenet HealthcareTHC | $20.6B | $256.44 | -2.15% | United States |
| 66 | STERISSTE | $20.5B | $209.98 | +0.57% | United States |
| 67 | ViatrisVTRS | $19.7B | $17.12 | -0.35% | United States |
| 68 | Zimmer BiometZBH | $17.3B | $90.88 | -3.30% | United States |
| 69 | MedpaceMEDP | $17.2B | $617.15 | -2.07% | United States |
| 70 | Jazz PharmaceuticalsJAZZ | $15.2B | $234.88 | -2.37% | Ireland |
| 71 | SolventumSOLV | $15.0B | $88.37 | -0.43% | United States |
| 72 | Ascendis Pharma A/SASND | $14.7B | $223.13 | -6.08% | Denmark |
| 73 | Neurocrine BiosciencesNBIX | $14.2B | $139.49 | -1.94% | United States |
| 74 | ExelixisEXEL | $14.1B | $56.73 | -2.44% | United States |
| 75 | Charles River Laboratories InternationalCRL | $13.2B | $277.33 | -2.73% | United States |
| 76 | UL SolutionsULS | $13.2B | $65.38 | -1.91% | United States |
| 77 | Summit TherapeuticsSMMT | $13.1B | $16.45 | -3.91% | United States |
| 78 | BridgeBio PharmaBBIO | $12.8B | $65.71 | -5.08% | United States |
| 79 | Halozyme TherapeuticsHALO | $12.8B | $112.44 | -2.34% | United States |
| 80 | PenumbraPEN | $12.6B | $319.44 | +0.02% | United States |
| 81 | IconICLR | $12.5B | $163.90 | -1.92% | Ireland |
| 82 | Fresenius Medical CareFMS | $12.5B | $22.41 | -0.40% | Germany |
| 83 | Corcept TherapeuticsCORT | $12.2B | $112.94 | -3.88% | United States |
| 84 | Baxter InternationalBAX | $12.1B | $23.49 | -0.80% | United States |
| 85 | Encompass HealthEHC | $12.1B | $122.21 | -0.45% | United States |
| 86 | Biomarin PharmaceuticalBMRN | $12.0B | $62.21 | -1.83% | United States |
| 87 | Madrigal PharmaceuticalsMDGL | $11.9B | $513.02 | -1.12% | United States |
| 88 | DavitaDVA | $11.7B | $183.14 | -0.32% | United States |
| 89 | Bio-TechneTECH | $11.4B | $72.52 | -0.04% | United States |
| 90 | Elanco Animal HealthELAN | $11.3B | $22.57 | -1.57% | United States |
| 91 | Smith & NephewSNN | $11.2B | $26.82 | -2.47% | United Kingdom |
| 92 | BrightSpring Health ServicesBTSG | $11.0B | $55.78 | -1.36% | United States |
| 93 | Universal Health ServicesUHS | $10.7B | $181.39 | +1.17% | United States |
| 94 | Cooper CompaniesCOO | $10.7B | $56.07 | +1.41% | United States |
| 95 | Align TechnologyALGN | $10.5B | $148.17 | -3.34% | United States |
| 96 | Twist BioscienceTWST | $10.5B | $158.50 | -3.71% | United States |
| 97 | Dr Reddys LaboratoriesRDY | $10.3B | $12.39 | -1.43% | India |
| 98 | Ensign GroupENSG | $10.2B | $175.46 | -0.49% | United States |
| 99 | Axsome TherapeuticsAXSM | $10.1B | $193.45 | -4.75% | United States |
| 100 | Krystal BiotechKRYS | $10.1B | $341.75 | -2.60% | United States |
Showing the largest 100 of 1,020 companies. One row per company, with secondary share classes folded into their primary listing. Updated 24 Sept 2026.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 500Biotechnology: Biological Products (No Diagnostic Substances) 160Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 9Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 28Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 5Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.